75% of Facebook users share political content without reading
HQ Team November 23, 2024: Social media has become a part of our social fabric. Research shows that people spend on an average.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 23, 2024: Social media has become a part of our social fabric. Research shows that people spend on an average.
HQ Team November 22, 2024: Researchers at the University of California, San Diego, have developed a wearable ultrasound patch that continuously monitors blood.
More than 30 nations, which combined account for 47% of global methane emissions from organic waste, signed a pact to reduce levels by.
A sedentary lifestyle of more than 10.6 hours a day increases heart disease by up to 60%, according to a study by Mass.
UN Secretary-General António Guterres outlined a three-point plan to limit global temperature rise to 1.5 degrees Celsius by 2030, including new ways to.
Toxic positivity promotes the belief that individuals should maintain happiness regardless of their circumstances. It discourages negative thoughts, even in situations that naturally.
One stillbirth occurs every 10 seconds and one-third of these occur between 20 and 28 weeks gestation, according to data from the Institute for.
Rheumatoid arthritis may be associated with higher amounts of bacteria accumulating in the gut ten months before clinical diagnosis, researchers reveal.
An international body of technical experts in the field of food security has issued an alert about an “imminent” and “substantial” likelihood of.
GSK Plc., will pay China’s privately-held Chimagen Biosciences $300 million upfront to develop and commercialise a T-cell engager to treat autoimmune diseases.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com